期刊文献+

A new synthesis route of cabazitaxel 被引量:3

一种合成卡巴他赛的新方法(英文)
原文传递
导出
摘要 A new route for the synthesis of cabazitaxel (Javanta) starting with 10-deacetylbaccatin III was developed. In this new procedure, a mild condition for the methylation of 7-OH was applied, thus the epimerization of 7β-OH under basic conditions was reduced. The total yield of this 6-step synthesis is 20%. 本文报道了一种以10-去乙酰基巴卡丁III为起始原料合成卡巴他赛的新方法。路线中使用了温和的条件对底物7-羟基进行甲醚化,从而避免了7β-羟基在强碱性条件下的差向异构化。该路线共6步,总收率为20%。
机构地区 中国医学科学院
出处 《Journal of Chinese Pharmaceutical Sciences》 CAS 2012年第5期472-476,共5页 中国药学(英文版)
基金 NSFC(Grant No.30930108) MOST(Grant No.2009YZH-LCH03)
关键词 CABAZITAXEL 7-OH Methylation 卡巴他赛 7-羟基甲基化
  • 相关文献

参考文献13

  • 1FDA Center for Drug Evaluation and Research. Approval Package for: Jevtana. June 17, 2010. Available from: http://www.fda.gov/AboutFDA/CentersOffices/Officeof MedicalProductsandTobacco/CDERJucm216214.htm. 被引量:1
  • 2Siegel, R.; Ward, E.; Brawley, O.; Jemal, A. CA-Cance J. Clin. 2011, 61,212-236. 被引量:1
  • 3Mita, A.C.; Denis, L.J.; Rowinsky, E.K.; DeBono, J.S Goetz, A.D.; Ochoa, L., Forouzesh, B.; Beeram, M Patnaik, A.; Molpus, K.; Semiond, D.; Besenval, M Tolcher, A.W. Clin. Cancer Res. 2009, 15, 723-730. 被引量:1
  • 4Sanofi-Aventis. Jevtana prescribing information. June 17, 2010. Available from: http://www.accessdata.fda.gov/ drugs at fda_docs/label/2010/201023 lbl .pdf. 被引量:1
  • 5Bradshaw, D.M.; Arceci, R.J.J. Clin. Oncol. 1998, 16, 3674-3690. 被引量:1
  • 6Borst, P.; Evers, R.; Kool, M.; Wijnholds, J. J. Natl. Cancer Inst. 2000, 92, 1295-1302. 被引量:1
  • 7Paller, C.J.; Antonarakis, S.E. Drug Des. Devel. Ther. 2011, 5, 117-124. 被引量:1
  • 8Bouchard, H.; Bourzat, J.D.; Commercon, A. US6372780, 2002. 被引量:1
  • 9Sun, X.Q.; Chen, X.; Yang, H.T.; Miao, C.B. CN 102285947A. 2011. 被引量:1
  • 10Zhang, W.Z.; Zhang, A.P.; Wang, Q.Y.; Yin, Z.C.; Huang, W.; Cai, Z.X.; Tong, Z.B.; Gao, S. CN 102311410A. 2012. 被引量:1

同被引文献16

  • 1JEMAL A,SIEGEL R,XU J,et al.Cancer statistics,2010[J].Cancer J Clin,2010,60(5):277-300. 被引量:1
  • 2SCHURKO B,OH W K.Docetaxel chemotherapy re-mains the standard of care in castration-resistant prostate cancer [J].Nat Clin Pract Oncol,2008,5(9):506-507. 被引量:1
  • 3PALLER C J,ANTONARAKIS E S.Cabazitaxel:a novel second-line treatment for metastatic castration-resistant prostate cancer [J].Drug Des Devel Ther,2011(5):117-124. 被引量:1
  • 4JORDAN M A,WILSON L.Microtubules as a target for anticancer drugs [J].Nat Rev Cancer,2004,4(4):253-265. 被引量:1
  • 5KINGSTON D G I.Tubulin-interactive natural pro-ducts as anticancer agents(1)[J].J Nat Prod,2009,72(3):507-515. 被引量:1
  • 6BOUCHARD H,BOURZAT J D,COMMERCON A.Methods of treating cell lines expressing multidrug resistance P-glycoprotein:US,6372780 [P].2002-04-06. 被引量:1
  • 7张伟中,张爱平,王权勇,等.一种卡巴他赛的制备方法:中国,102311410A[P].2012-01-11. 被引量:3
  • 8GUERITTE-VOEGELEIN F,SENILH V,DAVID B,et al.Chemical studies of 10-deacetyl baccatin Ⅲ:hemisynthesis of taxol derivatives [J].Tetrahedron,1986,42(16):4451-4460. 被引量:1
  • 9DENIS J N,GREENE A E,GUENARD D,et ah Highly efficient,practical approach to natural taxol [J].J Am Chem Soc,1988,110(17):5917-5919. 被引量:1
  • 10PARISED,LYON G O,SOLAIZE D P,et al.Process for preparing derivatives of the taxoid fami-ly:US,5962705 A[P].1999-10-05. 被引量:1

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部